Brugada Syndrome Substrate Characterization and Ablation
ConditionBrugada Syndrome
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMaria Cecilia Hospital
About this trial
Independent, single center, prospective study, to evaluate the efficacy, in consecutive BrS patients undergoing catheter ablation, at medium-long term follow-up after epicardial substrate homogenization. The target area is defined collecting signals using high density and high resolution mapping with equi-spaced electrode array. The ablation of abnormal fragmented prolonged low-frequency ventricular electrograms is performed by contact force catheter.
Eligibility criteria
Qualifiers
Symptomatic patients diagnosed with BrS-ECG pattern of types 1 and 2, both spontaneous and arising after Ajmaline tests, already implanted with an ICD.
Patients eligible for ablation with 3D high-density mapping system in accordance with national guidelines, IFU and according to medical decision;
Adult patients able to provide written informed consent
Disqualifiers
Patients unable to provide written informed consent;
Patients unable to guarantee their presence at future FU visits;
Patients who, according to medical judgment, have a life expectancy of less than 12 months;
Patients who have undergone cardiac ablation in the 90 days prior to enrollment.
Trial design
Treatments tested in this trial
- ablation
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov